Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-07-03

Clinical Trial Update: Phase III Efficacy and Safety Study of Oleogel-S10 in Epidermolysis Bullosa [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating Oleogel-S10 for Epidermolysis Bullosa has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oleogel-S10

Snippet

Sponsor: Amryt Research Limited | Conditions: Epidermolysis Bullosa | Phase 3 | Status: COMPLETED | Results posted: 2023-07-03